Clinical Trial Update: MAGnesium Effect With ANtiosteoporotic Drugs [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the effect of magnesium when given with antiosteoporotic drugs for postmenopausal osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Magnesium (magnesium)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Osteoporosis, Postmenopausal | Phase 2 | Status: COMPLETED